Dr Reddys Laboratories Stock Buy Hold or Sell Recommendation
RDY Stock | USD 75.49 0.25 0.33% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Dr Reddys Laboratories is 'Buy'. Macroaxis provides Dr Reddys buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RDY positions. The advice algorithm takes into account all of Dr Reddys' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Osisko Gold Ro's buy or sell advice are summarized below:
Real Value 71.93 | Target Price 70.11 | Hype Value 75.54 | Market Value 75.49 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Dr Reddys Laboratories given historical horizon and risk tolerance towards Dr Reddys. When Macroaxis issues a 'buy' or 'sell' recommendation for Dr Reddys Laboratories, the advice is generated through an automated system that utilizes algorithms and statistical models.
RDY |
Execute Dr Reddys Buy or Sell Advice
The RDY recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Dr Reddys Laboratories. Macroaxis does not own or have any residual interests in Dr Reddys Laboratories or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Dr Reddys' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Buy
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Dr Reddys Trading Alerts and Improvement Suggestions
Latest headline from news.google.com: Dr. Reddys Laboratories Share Price Today Live Updates Dr. Reddys Laboratories Sees 0.81 percent Increase in... - Economic Times |
Dr Reddys Returns Distribution Density
The distribution of Dr Reddys' historical returns is an attempt to chart the uncertainty of Dr Reddys' future price movements. The chart of the probability distribution of Dr Reddys stock daily returns describes the distribution of returns around its average expected value. We use Dr Reddys Laboratories price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Dr Reddys returns is essential to provide solid investment advice for Dr Reddys.
Mean Return | 0.21 | Value At Risk | -2.26 | Potential Upside | 1.86 | Standard Deviation | 1.23 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Dr Reddys historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
RDY Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Dr Reddys is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dr Reddys Laboratories backward and forwards among themselves. Dr Reddys' institutional investor refers to the entity that pools money to purchase Dr Reddys' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Gqg Partners Llc | 2023-12-31 | 437 K | Ameriprise Financial Inc | 2023-09-30 | 434.5 K | Millennium Management Llc | 2023-09-30 | 361.6 K | Grantham, Mayo, Van Otterloo & Co., Llc | 2023-12-31 | 329.1 K | Lazard Asset Management Llc | 2023-09-30 | 306.1 K | Acadian Asset Management Llc | 2023-09-30 | 270.3 K | Schroder Investment Management Group | 2023-12-31 | 266.7 K | Mondrian Investment Partners Ltd | 2023-09-30 | 216.1 K | Assenagon Asset Management Sa | 2023-12-31 | 196.1 K | Blackrock Inc | 2023-12-31 | 3 M | Royal Bank Of Canada | 2023-09-30 | 2.1 M |
Dr Reddys Cash Flow Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (1.5B) | (9.9B) | (5.3B) | (2.7B) | (2.4B) | (2.5B) | |
Dividends Paid | 3.9B | 4.1B | 4.1B | 5.0B | 5.7B | 6.0B | |
Capital Expenditures | 6.1B | 12.6B | 19.0B | 18.9B | 21.7B | 22.8B | |
Net Income | 19.5B | 19.1B | 23.6B | 60.5B | 69.6B | 73.0B | |
End Period Cash Flow | 2.0B | 14.8B | 14.9B | 5.8B | 6.6B | 6.3B | |
Change In Cash | (266M) | 12.9B | 32M | (9.1B) | (10.4B) | (9.9B) | |
Free Cash Flow | 23.7B | 23.1B | 9.1B | 40.0B | 46.0B | 48.3B | |
Depreciation | 12.5B | 12.8B | 11.8B | 12.5B | 14.4B | 15.1B | |
Other Non Cash Items | 6.4B | 2.3B | (2.7B) | (22.0B) | (25.2B) | (24.0B) | |
Change To Netincome | (4.1B) | 5.4B | 12.0B | 6.6B | 7.6B | 8.0B | |
Investments | (4.9B) | 4.1B | (11.2B) | (41.4B) | (37.2B) | (35.4B) | |
Net Borrowings | (15.2B) | (19.2B) | 6.1B | 2.7B | 2.5B | 2.6B |
Dr Reddys Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Dr Reddys or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Dr Reddys' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a RDY stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.16 | |
β | Beta against NYSE Composite | 0.29 | |
σ | Overall volatility | 1.20 | |
Ir | Information ratio | 0.05 |
Dr Reddys Volatility Alert
Dr Reddys Laboratories has relatively low volatility with skewness of 0.07 and kurtosis of 0.66. However, we advise all investors to independently investigate Dr Reddys Laboratories to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Dr Reddys' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Dr Reddys' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.Dr Reddys Fundamentals Vs Peers
Comparing Dr Reddys' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Dr Reddys' direct or indirect competition across all of the common fundamentals between Dr Reddys and the related equities. This way, we can detect undervalued stocks with similar characteristics as Dr Reddys or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Dr Reddys' fundamental indicators could also be used in its relative valuation, which is a method of valuing Dr Reddys by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Dr Reddys to competition |
Fundamentals | Dr Reddys | Peer Average |
Return On Equity | 0.21 | -0.31 |
Return On Asset | 0.12 | -0.14 |
Profit Margin | 0.19 % | (1.27) % |
Operating Margin | 0.25 % | (5.51) % |
Current Valuation | 11.98 B | 16.62 B |
Shares Outstanding | 166.52 M | 571.82 M |
Shares Owned By Institutions | 15.00 % | 39.21 % |
Number Of Shares Shorted | 648.12 K | 4.71 M |
Price To Earning | 31.58 X | 28.72 X |
Price To Book | 3.87 X | 9.51 X |
Price To Sales | 0.05 X | 11.42 X |
Revenue | 245.88 B | 9.43 B |
Gross Profit | 113.84 B | 27.38 B |
EBITDA | 108.78 B | 3.9 B |
Net Income | 60.48 B | 570.98 M |
Cash And Equivalents | 2.93 B | 2.7 B |
Cash Per Share | 208.58 X | 5.01 X |
Total Debt | 13.47 B | 5.32 B |
Debt To Equity | 0.12 % | 48.70 % |
Current Ratio | 1.98 X | 2.16 X |
Book Value Per Share | 1,609 X | 1.93 K |
Cash Flow From Operations | 58.87 B | 971.22 M |
Short Ratio | 2.90 X | 4.00 X |
Earnings Per Share | 3.78 X | 3.12 X |
Price To Earnings To Growth | 4.93 X | 4.89 X |
Target Price | 78.15 | |
Number Of Employees | 25.86 K | 18.84 K |
Beta | 0.35 | -0.15 |
Market Capitalization | 12.66 B | 19.03 B |
Total Asset | 322.85 B | 29.47 B |
Retained Earnings | 215.59 B | 9.33 B |
Working Capital | 118.53 B | 1.48 B |
Current Asset | 1.81 B | 9.34 B |
Dr Reddys Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as RDY . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Dr Reddys Buy or Sell Advice
When is the right time to buy or sell Dr Reddys Laboratories? Buying financial instruments such as RDY Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 41.6B | 48.9B | 56.2B | 59.0B | Total Assets | 296.7B | 322.9B | 371.3B | 206.1B |
Use Investing Ideas to Build Portfolios
In addition to having Dr Reddys in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Growth Funds Thematic Idea Now
Large Growth Funds
Funds or Etfs that invest in stocks of large-sized companies with above-average risk and growth rate. The Large Growth Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Growth Funds Theme or any other thematic opportunities.
View All Next | Launch |
Check out Dr Reddys Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for RDY Stock analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.103 | Dividend Share 40 | Earnings Share 3.78 | Revenue Per Share 272.4618 | Quarterly Revenue Growth 0.066 |
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.